browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
8c1299ab-3562-4669-adbf-708ecc08acd3
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-19 22:24:26
Income (reported)
$50,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

CROSSROADS STRATEGIES, LLC

lobbying firm

Contact
MATHEW LAPINSKI
Phone
+1 202-559-0170
Address
zip:20002, city:Washington, state:DC, street:800 North Capitol Street, NW, Suite 800
Client

TAKEDA PHARMACEUTICALS AMERICA, INC.

pharmaceutical company

State
IL
Country
US
Government-entity client
false
Effective date
2012-10-01
Issues lobbied + lobbyists (6)

HCR — Health Issues

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, plasma therapy, step therapy, and PBM reform; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Issues related to tax reform; R&D tax credit; orphan drug tax credit; Section 899; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CPT — Copyright/Patent/Trademark

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

ENV — Environment/Superfund

Issues related to permitting.

Lobbyists:

Government entities lobbied: Environmental Protection Agency (EPA)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.